Skip to content

DR.LEEN THIJS

Active
Private limited companyfounded 2013active for 13 yearsAlbertkanaalstraat 35, 3511 Hasselt, BelgiumKBO/BCE: BE 0524.939.056
Summary

DR.LEEN THIJS has been active since 2013 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €157,829 and a net result of €37,171. Equity has been growing by about 13% per year since 2018. Its solvency ranks better than 35% of 20,678 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 26-03-2013 Normal situation
Activity
Specialist medical practice NACE 86220
Joint committee
330.04 Paritair Comité voor de gezondheidsinrichtingen en -diensten · annual accounts 2025
Establishment unit
2.266.320.965 3511 Hasselt, since 17-07-2017
Financial year end
31 December
Peppol
Reachable

Board and ownership

Board

Financial position

94 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€106,540
=
Turnover
≈ €200,000
estimated
Profit
€37,171
▲ 5.1%
Equity
€157,829
▲ 30.8%
Total assets
€350,979
▲ 5.7%
Employees on 31-12-2025
1
=
Filed on 08-07-2026, 23 days before the deadline
Score breakdownlowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 3.12, cash €175,545Size: total assets €350,979Figures for financial year 2025 (filed on 08-07-2026)Show the evidence

Checked score

Score 2025
94 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 55% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 70+9
equity 45.0% of total assets
Liquidity 96+1
short-term debt 16.5% · cash 50.0%
Profitability 82=
return on assets 10.6%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Last 24 months 12-2024: < 0.1% 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026highest value 08-2026: < 0.1%● unchanged vs 07-2026lowest value 09-2026: < 0.1%● unchanged vs 08-2026lowest value 10-2026: < 0.1%● unchanged vs 09-2026 11-2026: < 0.1%● unchanged vs 10-2026
Credit of up to €14,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 3.12 (2.27 in 2024), above the usual 1.5. Short-term debt is 16.5% and cash 50% of total assets. However, 55% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 36% of them on solvency, 84% on liquidity, 30% on profitability and 72% on growth.

The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 3.12, cash €175,545
NBB · annual accounts
lowers risk · Size: total assets €350,979
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 08-07-2026)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 08-07-2026, 23 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
23 days early
2024
31 days early
2023
34 days early
2022
14 days early
2021
4 days early
2020
17 days late
2019
3 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 13 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 8 July (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: 8 profitable years in a rowprofit 2025: €37,171 8 years View
  • Positive: Filed on time since financial year 2021accounts within the deadline every year 5 years View

Comparable companies

These companies have the same main activity as DR.LEEN THIJS: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €317,000 and €393,000, founded between 2011 and 2014.

CompanyTotal assetsGross margin
DR.LEEN THIJS Hasselt€350,979€106,540
DOCTEUR SOPHIE ANRIJS PNEUMOLOGIE SPRL Chaumont-Gistoux€317,047€106,203
Dr. Nathalie Blockx Sint-Katelijne-Waver€377,478€112,889
DERMADOK Antwerpen€370,210€97,745
Cabinet de dermatologie B. Cawet Chimay€328,050€117,813
Dr. Asscherickx Willeke, pediatrie Herent€355,651€97,681
SOCIETE MEDICO-CHIRURGICALE L'ECTODERME Colfontaine€392,808€105,943
Full comparison

Key facts about DR.LEEN THIJS

What is the company number of DR.LEEN THIJS?
The company number of DR.LEEN THIJS is 0524.939.056. The VAT number is the same number with BE in front: BE 0524.939.056.
Where is DR.LEEN THIJS based?
The registered office is at Albertkanaalstraat 35, 3511 Hasselt.Company details
What does DR.LEEN THIJS do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of DR.LEEN THIJS?
The legal form of DR.LEEN THIJS is Private limited company (BV).
When was DR.LEEN THIJS founded?
DR.LEEN THIJS was founded on 26-03-2013.
Is DR.LEEN THIJS still active?
Yes, DR.LEEN THIJS is an active enterprise in the KBO register.
How many employees does DR.LEEN THIJS have?
DR.LEEN THIJS had an average of 1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does DR.LEEN THIJS fall under?
In its 2025 annual accounts, DR.LEEN THIJS states joint committee 330.04 (Paritair Comité voor de gezondheidsinrichtingen en -diensten).
What is the turnover of DR.LEEN THIJS?
The turnover in financial year 2025 is ≈ €200,000. This figure is estimated from the gross margin of €106,540 and 43 comparable companies (NACE 86220). It probably lies between €170,000 and €260,000.
Is DR.LEEN THIJS profitable?
In financial year 2025, DR.LEEN THIJS made a profit of €37,171.
Where can I find the annual accounts of DR.LEEN THIJS?
DR.LEEN THIJS filed 13 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DR.LEEN THIJS due?
DR.LEEN THIJS must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.